{"schema_version":"secwatch.filing_event.v1","accession":"0000856982-24-000094","form_type":"8-K","ticker":"MMSI","cik":"0000856982","company_name":"MERIT MEDICAL SYSTEMS INC","filed_at":"2024-10-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.160634+00:00","generated_at":"2026-05-30T08:44:57.423189+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Merit Medical Q3 revenue up 7.8% to $339.8M, non-GAAP EPS $0.86, raises guidance","bullets":["Revenue $339.8M (+7.8% YoY); GAAP EPS $0.48 (+8.0%); non-GAAP EPS $0.86 (+21.1%).","Non-GAAP operating margin 19.2% vs 17.4% prior year; free cash flow $120M in 9 months (+116%).","Acquired assets from EndoGastric Solutions (EsophyX Z+ for GERD treatment).","Entered asset purchase for Cook Medical lead management portfolio; closing expected Nov 1, 2024.","Raised full-year guidance; specifics not detailed in press release excerpt."],"urls":{"canonical":"https://secwatch.observer/filing/0000856982-24-000094","json":"https://secwatch.observer/filing/0000856982-24-000094.json","markdown":"https://secwatch.observer/filing/0000856982-24-000094.md","text":"https://secwatch.observer/filing/0000856982-24-000094.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/856982/000085698224000094/0000856982-24-000094-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/856982/000085698224000094/mmsi-20241030x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T08:44:57.423189+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}